These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Malaria: epidemiology, pathogenesis, diagnosis, prevention, and treatment--an update. Ryan ET. Curr Clin Top Infect Dis; 2001 Sep 29; 21():83-113. PubMed ID: 11572163 [No Abstract] [Full Text] [Related]
4. Cotrimoxazole, clinical uses and malaria chemotherapy. Fehintola FA. Afr J Med Med Sci; 2010 Mar 29; 39(1):63-8. PubMed ID: 20632674 [Abstract] [Full Text] [Related]
5. Epidemiological and operational considerations in the use of antimalarial drugs for chemotherapy and chemoprophylaxis of malaria in Africa. Campbell CC, Nguyen-Dinh P, Breman JG. Ann Soc Belg Med Trop; 1985 Mar 29; 65 Suppl 2():165-70. PubMed ID: 3907534 [No Abstract] [Full Text] [Related]
6. Drug resistance in malaria: its population biology and implications for control. Babiker HA, Mackinnon MJ. Acta Trop; 2005 Jun 29; 94(3):161-2. PubMed ID: 15862285 [No Abstract] [Full Text] [Related]
7. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. Malamba SS, Mermin J, Reingold A, Lule JR, Downing R, Ransom R, Kigozi A, Hunt BM, Hubbard A, Rosenthal PJ, Dorsey G. Am J Trop Med Hyg; 2006 Sep 29; 75(3):375-80. PubMed ID: 16968909 [Abstract] [Full Text] [Related]
8. Malaria chemoprophylaxis for multiple drug resistant Plasmodium falciparum in Africa: an increasing problem. van der Kaay HJ, Overbosch D, Stuiver PC, Wismans PJ. Trop Geogr Med; 1984 Dec 29; 36(4):317-22. PubMed ID: 6396911 [Abstract] [Full Text] [Related]
10. Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation. Hamel MJ, Poe A, Bloland P, McCollum A, Zhou Z, Shi YP, Ouma P, Otieno K, Vulule J, Escalante A, Udhayakumar V, Slutsker L. Trans R Soc Trop Med Hyg; 2008 Apr 29; 102(4):338-45. PubMed ID: 18321547 [Abstract] [Full Text] [Related]
11. [Resistance of Plasmodium falciparum to antimalarials: practical implications and control prospects]. Onori E. Parassitologia; 1981 Dec 29; 23(1-3):31-62. PubMed ID: 6760055 [Abstract] [Full Text] [Related]
12. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1985 Apr 12; 34(14):185-90, 195. PubMed ID: 3156271 [No Abstract] [Full Text] [Related]
13. Anti malarial drugs for prevention of malaria. Mathew JL. Indian Pediatr; 2008 Aug 12; 45(8):681-3. PubMed ID: 18723912 [No Abstract] [Full Text] [Related]
15. [Scandinavian recommendations on prevention of malaria]. Rahka B, Pettersson T. Nord Med; 1987 Aug 12; 102(8-9):240. PubMed ID: 3313269 [No Abstract] [Full Text] [Related]